News for Lupin Limited (LUPIN.NS)

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over the last six months, the price fell by 10.12%, while in the past three months, it dropped by 4.86%. In the last month, the price declined by 7.76%.

The Nifty Pharma index closed 0.22 per cent down at 20378.3.

The Nifty Pharma index was trading 0.8 per cent up at 19978.6.

The Nifty Pharma index was trading 0.33 per cent down at 19814.9.

The Nifty Pharma index closed 0.33 per cent up at 19879.8.

The Nifty Pharma index was trading 0.64 per cent down at 19687.35.

The Nifty Pharma index closed 1.92 per cent down at 19813.5.

The Nifty Pharma index was trading 0.61 per cent down at 20125.55.

The Nifty Pharma index was trading 0.13 per cent down at 20362.85.

Markets remained range-bound with Nifty and Bank Nifty forming Doji patterns, signaling indecisiveness. FII selling pressure continues, keeping the market under check. Rajesh Palviyas stock picks for next week include SBI Life and Hindalco (Buy), Lupin (Short). While oversold conditions suggest a technical rebound, sustained recovery depends on FII outflows easing.

The Nifty Pharma index closed 1.92 per cent down at 20385.65.

The Nifty Pharma index was trading 0.17 per cent down at 20783.9.

Indian markets have witnessed a sharp correction over the last five months owing to multiple macro reasons and a cut in overall earnings expectations. Out of the 5,684 stocks listed on the BSE, 3,446 stocks have declined in the last five months, while from the NSE Nifty 500, 458 stocks have declined in the same period. However, it appears that there are multiple stocks that have been weighed down much more owing to macro reasons as these have actually seen earnings upgrade.

The Nifty Pharma index closed 0.71 per cent down at 20820.0.

The Nifty Pharma index was trading 0.67 per cent down at 20828.3.

The Nifty Pharma index closed 1.27 per cent up at 21076.0.

The Nifty Pharma index was trading 2.69 per cent down at 20850.3.

The Nifty Pharma index closed 0.51 per cent down at 21142.05.

Lupin Limited reports 39.5% profit increase, strong performance in North America and Europe, maintaining market leadership in US generics.